FGFR2/CD332 Rekombinanter Antikörper

FGFR2/CD332 Rekombinant Antikörper für FC

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

FC

Konjugation

Unkonjugiert

CloneNo.

241383D11

Kat-Nr. : 98244-1-RR

Synonyme

FGFR2, CFD1, CEK3, CD332, BFR 1



Geprüfte Anwendungen

Erfolgreiche Detektion in FCTransfected HEK-293T cells

Empfohlene Verdünnung

AnwendungVerdünnung
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

98244-1-RR bindet in FC FGFR2/CD332 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Rekombinantes Protein
Vollständiger Name fibroblast growth factor receptor 2
Berechnetes Molekulargewicht92kd
GenBank-ZugangsnummerNM_000141.4
Gene symbol FGFR2
Gene ID (NCBI) 2263
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS with 0.09% sodium azide
LagerungsbedingungenStore at 2 - 8°C. Stable for one year after shipment.

Hintergrundinformationen

FGFR2 (Fibroblast growth factor receptor 2), also known as CD332, is a tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration, and apoptosis. Ligand binding leads to the activation of several signaling pathways, such as RAS, MAPK1/ERK2, MAPK3/ERK1, and the MAP Kinase signaling pathway, as well as the AKT1 signaling pathway. Mutations in the gene of FGFR2 are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
FC protocol for FGFR2/CD332 antibody 98244-1-RRDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen